The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.
Open accessAbstract
In a study of 307 white patients who underwent coronary angiography, the relationship of coronary artery disease (CAD) to plasma levels of lipoprotein Lp(a) and other lipid-lipoprotein variables was examined. Lp(a) resembles low-density lipoprotein (LDL) in several ways, but can be distinguished and quantified by electroimmunoassay. CAD was rated as present or absent and was also represented by a quantitative lesion score derived from estimates of stenosis in four major coronary vessels. Coronary lesion scores significantly correlated with Lp(a), total cholesterol, triglycerides, LDL cholesterol, and high-density lipoprotein (HDL) cholesterol levels by univariate statistical analysis. By multivariate analysis levels of Lp(a) were associated significantly and independently with the presence of CAD (p less than .02), and tended to correlate with lesion scores (p = .06). Among subgroups Lp(a) level was associated with CAD in women of all ages and in men 55 years old or younger. An apparent threshold for coronary risk occurred at Lp(a) lipoprotein mass concentrations of 30 to 40 mg/dl, corresponding to Lp(a) cholesterol concentrations of approximately 10 to 13 mg/dl. Plasma Lp(a) in white patients appears to be a major coronary risk factor with an importance approaching that of the level of LDL or HDL cholesterol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Klecka, W. (1980) · Sage eBooks · doi:10.4135/9781412983938 · Cited by 3,723
Lipoprotein Lp(a) and the risk for myocardial infarction
Kostner, G. M., Avogaro, P., Cazzolato, G., Marth, E., Bittolo-Bon, G., & Qunici, G. B. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90103-9 · Cited by 687
Sniderman, A., Shapiro, S., Marpole, D., Skinner, B., Teng, B., & Kwiterovich, P. O. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.604 · Cited by 633
Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., & Mao, S. J. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090701 · Cited by 537
Miller, N. E., Hammett, F., Saltissi, S., Rao, S., van Zeller, H., Coltart, J., & Lewis, B. (1981) · BMJ · doi:10.1136/bmj.282.6278.1741 · Cited by 482
Human plasma lipoprotein [a]. Structural properties.
Gaubatz, J. W., Heideman, C., Gotto, A. M., Morrisett, J. D., & Dahlen, G. H. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32663-2 · Cited by 453
Self-citationLp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction
MURAI, A., MIYAHARA, T., FUJIMOTO, N., MATSUDA, M., & KAMEYAMA, M. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90048-1 · Cited by 383
DIAMOND, G., & FORRESTER, J. S. (1972) · Circulation · doi:10.1161/01.cir.45.1.11 · Cited by 345
Turnover of Lipoprotein (a) in Man
Krempler, F., Kostner, G. M., Bolzano, K., & Sandhofer, F. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109813 · Cited by 278
Radioimmunoassay of human plasma Lp(a) lipoprotein
Albers, J. J., Adolphson, J. L., & Hazzard, W. R. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41683-9 · Cited by 268
Patsch, J. R., Sailer, S., Kostner, G., Sandhofer, F., Holasek, A., & Braunsteiner, H. (1974) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36783-3 · Cited by 261
Severity of coronary atherosclerosis related to lipoprotein concentration.
Jenkins, P. J., Harper, R. W., & Nestel, P. J. (1978) · BMJ · doi:10.1136/bmj.2.6134.388 · Cited by 255
Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B.
Guyton, J. R., Dahlen, G. H., Patsch, W., Kautz, J. A., & Gotto, A. M. (1985) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.5.3.265 · Cited by 238
Self-citationAlbers, J. J., Taggart, H. M., Applebaum-Bowden, D., Haffner, S., Chesnut, C. H., & Hazzard, W. R. (1984) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(84)90078-x · Cited by 187
Whayne, T. F., Alaupovic, P., Curry, M. D., Lee, E. T., Anderson, P. S., & Schechter, E. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90026-5 · Cited by 179
Discriminative value of lipids and apoproteins in coronary heart disease
De Backer, G., Rosseneu, M., & Deslypere, J. P. (1982) · Atherosclerosis · doi:10.1016/0021-9150(82)90150-2 · Cited by 170
Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man.
Krempler, F., Kostner, G. M., Roscher, A., Haslauer, F., Bolzano, K., & Sandhofer, F. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110896 · Cited by 157
Albers, J. J., Cabana, V. G., Warnick, G. R., & Hazzard, W. R. (1975) · Metabolism · doi:10.1016/0026-0495(75)90098-0 · Cited by 152
Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a)
Vessby, B., Kostner, G. M., Lithell, H., & Thomis, J. A. (1982) · Atherosclerosis · doi:10.1016/0021-9150(82)90053-3 · Cited by 145
Relationship between plasma lipid concentrations and coronary artery disease in 496 patients.
Gotto, A. M., Gorry, G. A., Thompson, J. R., Cole, J. S., Trost, R., Yeshurun, D., & DeBakey, M. E. (1977) · Circulation · doi:10.1161/01.cir.56.5.875 · Cited by 136
Self-citationDahlén, G., Berg, K., Gillnäs, T., & Ericson, C. (1975) · Clinical Genetics · doi:10.1111/j.1399-0004.1975.tb00338.x · Cited by 113
Association of risk factor variables and coronary artery disease documented with angiography.
Holmes, D. R., Elveback, L. R., Frye, R. L., Kottke, B. A., & Ellefson, R. D. (1981) · Circulation · doi:10.1161/01.cir.63.2.293 · Cited by 107
Serum Lipids in Angiographically Assessed Coronary Atherosclerosis
Frick, M. H., Dahlén, G. H., Berg, K., et al. (1978) · CHEST Journal · doi:10.1378/chest.73.1.62 · Cited by 95
Self-citationStudies on an extra pre-beta lipoprotein fraction.
Dahlén, G., Ericson, C., Furberg, C. D., Lundkvist, L., & Svärdsudd, K. (1972) · PubMed · Cited by 85
Berg, K., Dahlén, G. H., & Børresen‐Dale, A. (1979) · Clinical Genetics · doi:10.1111/j.1399-0004.1979.tb01014.x · Cited by 83
RISK FACTORS AND ANGIOGRAPHICALLY DETERMINED CORONARY OCCLUSION
Anderson, A. J., Barboriak, J. J., & Rimm, A. A. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112511 · Cited by 81
Guyton, J. R., Bocan, T. M. A., & Schifani, T. A. (1985) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.5.6.644 · Cited by 74
Self-citation
Cited by
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., Faire, U., Dahlén, G., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474
The mysteries of lipoprotein(a).
Utermann, G. (1989) · Science · doi:10.1126/science.2530631 · Cited by 1,257
Estrogen and coronary heart disease in women
Barrett-Connor, E. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460140089033 · Cited by 1,241
Metadata
- Authors
- Dahlen, G. H., Guyton, J. R., Attar, M., Farmer, J. A., Kautz, J. A., & Gotto, A. M.
- Venue
- Circulation
- Published
- 1986-10
- Volume
- 74
- Issue
- 4
- Pages
- 758-765
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2012098057
- Cited by
- 911
- References
- 28
- FWCI
- 20.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.